Actively Recruiting
Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain
Led by The Third Affiliated hospital of Zhejiang Chinese Medical University · Updated on 2025-12-30
290
Participants Needed
1
Research Sites
68 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to objectively evaluate the effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation (PC-TEAS) on improving the quality of life in patients with chronic cancer pain, thereby providing evidence-based medical support for its efficacy and offering practical basis for patients to achieve home-based auxiliary treatment based on their own needs. Furthermore, by observing and comparing changes in indicators such as pain-related scores, analgesic consumption, emotional scores, spontaneous bowel movements, and adverse events, this research will comprehensively assess the advantages of PC-TEAS in the management of chronic cancer pain and explore other potential benefits of this intervention for patients.
CONDITIONS
Official Title
Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years, regardless of gender
- Confirmed diagnosis of primary or metastatic malignant tumor by histopathology or cytology
- Cancer-related pain with average Numeric Rating Scale score of 2 or higher in the past week or regular use of opioid analgesics
- Life expectancy of at least 3 months
- Eastern Cooperative Oncology Group Performance Status score of 2 or less, stable vital signs, clear consciousness, intact pain perception, and ability to cooperate and complete assessments
- Signed informed consent provided by patient or legal guardian after full explanation of the study
You will not qualify if you...
- Pain not caused by cancer
- Severe heart or lung problems, or respiratory depression
- Presence of cardiac pacemaker or metal implants at stimulation sites
- Skin problems that prevent use of TEAS at acupoint sites
- Severe psychiatric disorders or major cognitive impairment
- Participation in other clinical trials that might affect this study's results
- Previous use of transcutaneous electrical acupoint stimulation (TEAS) or transcutaneous electrical nerve stimulation (TENS)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Third Affiliated Hospital of Zhejiang Chinese Medicinal University
Zhejiang, Hangzhou, China, 310053
Actively Recruiting
Research Team
Y
Yi Liang, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here